Hemolytic-Uremic Syndrome clinical trials at UCSF
1 research study open to eligible people
Hemolytic-uremic syndrome is a type of kidney disease. A clinical trial at UCSF is testing a new medicine called crovalimab for people with atypical hemolytic uremic syndrome. The trial will see if crovalimab is safe and effective in treating the disease.
Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
open to eligible people ages 12 years and up
This study aims to evaluate the efficacy and safety of crovalimab in adult and adolescent participants with aHUS.
San Francisco, California and other locations